$1.77 Billion is the total value of Boxer Capital, LLC's 51 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 49.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRTX | MIRATI THERAPEUTICS INC | $221,067,000 | +65.4% | 1,715,560 | 0.0% | 12.50% | +29.0% | |
| IMMU | Buy | IMMUNOMEDICS INC | $178,802,000 | +94.0% | 8,450,000 | +21.6% | 10.11% | +51.3% |
| BGNE | BEIGENE LTDsponsored adr | $153,328,000 | +35.4% | 925,000 | 0.0% | 8.67% | +5.6% | |
| ODT | ODONATE THERAPEUTICS INC | $109,142,000 | +24.7% | 3,363,377 | 0.0% | 6.17% | -2.8% | |
| MDCO | Buy | MEDICINES CO | $82,137,000 | +119.0% | 967,000 | +28.9% | 4.64% | +70.8% |
| SWTX | SPRINGWORKS THERAPEUTICS INC | $79,902,000 | +77.5% | 2,075,905 | 0.0% | 4.52% | +38.5% | |
| DBVT | Buy | DBV TECHNOLOGIES S Asponsored adr | $68,315,000 | +49.9% | 6,384,598 | +20.5% | 3.86% | +16.9% |
| ALLK | ALLAKOS INC | $64,368,000 | +21.3% | 675,000 | 0.0% | 3.64% | -5.4% | |
| ESPR | ESPERION THERAPEUTICS INC NE | $58,139,000 | +62.7% | 975,000 | 0.0% | 3.29% | +26.9% | |
| SGEN | New | SEATTLE GENETICS INC | $57,130,000 | – | 500,000 | +100.0% | 3.23% | – |
| QURE | Sell | UNIQURE NV | $54,849,000 | +61.0% | 765,400 | -11.6% | 3.10% | +25.6% |
| LABD | New | DIREXION SHS ETF TRdaily s&p biotec | $35,630,000 | – | 2,885,000 | +100.0% | 2.02% | – |
| GOSS | Buy | GOSSAMER BIO INC | $34,152,000 | -2.0% | 2,185,000 | +5.3% | 1.93% | -23.5% |
| RCKT | ROCKET PHARMACEUTICALS INC | $33,367,000 | +95.4% | 1,466,051 | 0.0% | 1.89% | +52.4% | |
| ARGX | ARGENX SEsponsored adr | $32,104,000 | +40.9% | 200,000 | 0.0% | 1.82% | +9.9% | |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $29,034,000 | -29.9% | 225,000 | -59.1% | 1.64% | -45.3% |
| KDMN | Buy | KADMON HLDGS INC | $28,113,000 | +178.9% | 6,205,882 | +55.1% | 1.59% | +117.5% |
| BCEL | ATRECA INC | $26,819,000 | +26.4% | 1,733,583 | 0.0% | 1.52% | -1.4% | |
| SAGE | New | SAGE THERAPEUTICS INC | $25,267,000 | – | 350,000 | +100.0% | 1.43% | – |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $24,496,000 | +45.3% | 800,000 | +14.3% | 1.38% | +13.2% |
| MTNB | MATINAS BIOPHARMA HLDGS INC | $23,127,000 | +260.0% | 10,188,312 | 0.0% | 1.31% | +180.7% | |
| FOLD | AMICUS THERAPEUTICS INC | $22,646,000 | +21.4% | 2,325,000 | 0.0% | 1.28% | -5.3% | |
| CABA | New | CABALETTA BIO INC | $21,882,000 | – | 1,566,361 | +100.0% | 1.24% | – |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $21,138,000 | -30.3% | 250,000 | -44.4% | 1.20% | -45.6% |
| ANAB | New | ANAPTYSBIO INC | $21,125,000 | – | 1,300,000 | +100.0% | 1.20% | – |
| GBT | GLOBAL BLOOD THERAPEUTICS IN | $19,873,000 | +63.8% | 250,000 | 0.0% | 1.12% | +27.9% | |
| ACHN | Buy | ACHILLION PHARMACEUTICALS IN | $18,210,000 | +152.9% | 3,000,000 | +50.0% | 1.03% | +97.3% |
| PRVL | PREVAIL THERAPEUTICS INC | $17,779,000 | +28.9% | 1,123,105 | 0.0% | 1.01% | +0.6% | |
| MIST | MILESTONE PHARMACEUTICALS IN | $17,646,000 | -14.2% | 1,102,194 | 0.0% | 1.00% | -33.0% | |
| RCUS | Buy | ARCUS BIOSCIENCES INC | $16,890,000 | +518.7% | 1,672,233 | +457.4% | 0.96% | +382.3% |
| VXX | New | BARCLAYS BK PLCipath b shrt trm | $15,120,000 | – | 1,000,000 | +100.0% | 0.86% | – |
| ARVN | New | ARVINAS INC | $15,039,000 | – | 366,000 | +100.0% | 0.85% | – |
| BLU | BELLUS HEALTH INC NEW | $13,490,000 | +18.9% | 1,775,000 | 0.0% | 0.76% | -7.2% | |
| NLTX | New | NEOLEUKIN THERAPEUTICS INC | $12,434,000 | – | 1,009,255 | +100.0% | 0.70% | – |
| RLMD | New | RELMADA THERAPEUTICS INC | $11,700,000 | – | 300,000 | +100.0% | 0.66% | – |
| KURA | KURA ONCOLOGY INC | $11,616,000 | -9.4% | 844,789 | 0.0% | 0.66% | -29.3% | |
| LXRX | Buy | LEXICON PHARMACEUTICALS INC | $11,516,000 | +53.0% | 2,775,000 | +11.0% | 0.65% | +19.2% |
| AKRO | AKERO THERAPEUTICS INC | $10,709,000 | -2.4% | 482,495 | 0.0% | 0.61% | -23.9% | |
| MRNS | New | MARINUS PHARMACEUTICALS INC | $10,368,000 | – | 4,800,000 | +100.0% | 0.59% | – |
| New | MEDICINES COcall | $8,494,000 | – | 100,000 | +100.0% | 0.48% | – | |
| SELB | New | SELECTA BIOSCIENCES INC | $7,816,000 | – | 3,284,072 | +100.0% | 0.44% | – |
| MIRM | New | MIRUM PHARMACEUTICALS INC | $7,773,000 | – | 317,000 | +100.0% | 0.44% | – |
| MEIP | MEI PHARMA INC | $7,224,000 | +47.6% | 2,913,091 | 0.0% | 0.41% | +15.2% | |
| IDYA | IDEAYA BIOSCIENCES INC | $5,732,000 | -16.7% | 764,252 | 0.0% | 0.32% | -35.1% | |
| SLDB | Sell | SOLID BIOSCIENCES INC | $4,592,000 | -88.6% | 1,031,872 | -73.5% | 0.26% | -91.1% |
| CBAY | Buy | CYMABAY THERAPEUTICS INC | $3,920,000 | -38.8% | 2,000,000 | +60.0% | 0.22% | -52.2% |
| KALV | KALVISTA PHARMACEUTICALS INC | $3,562,000 | +53.5% | 200,000 | 0.0% | 0.20% | +19.6% | |
| KNSA | KINIKSA PHARMACEUTICALS LTD | $3,214,000 | +30.0% | 290,577 | 0.0% | 0.18% | +1.7% | |
| LJPC | LA JOLLA PHARMACEUTICAL CO | $3,046,000 | -55.3% | 775,000 | 0.0% | 0.17% | -65.2% | |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $2,195,000 | -26.5% | 250,000 | -37.5% | 0.12% | -42.9% |
| CLRB | CELLECTAR BIOSCIENCES INC | $2,070,000 | +12.5% | 920,000 | 0.0% | 0.12% | -12.0% | |
| NVUS | Exit | NOVUS THERAPEUTICS INC | $0 | – | -324,383 | -100.0% | -0.02% | – |
| PRTA | Exit | PROTHENA CORP PLC | $0 | – | -79,598 | -100.0% | -0.04% | – |
| MRSN | Exit | MERSANA THERAPEUTICS INC. | $0 | – | -1,680,800 | -100.0% | -0.19% | – |
| Exit | IMMUNOMEDICS INCcall | $0 | – | -600,000 | -100.0% | -0.58% | – | |
| AVRO | Exit | AVROBIO INC | $0 | – | -600,000 | -100.0% | -0.61% | – |
| VYGR | Exit | VOYAGER THERAPEUTICS INC | $0 | – | -500,000 | -100.0% | -0.62% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -300,000 | -100.0% | -0.87% | – |
| WVE | Exit | WAVE LIFE SCIENCES LTD | $0 | – | -1,000,000 | -100.0% | -1.49% | – |
| PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -1,000,000 | -100.0% | -2.45% | – |
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -3,500,000 | -100.0% | -3.85% | – |
| ONCE | Exit | SPARK THERAPEUTICS INC | $0 | – | -1,650,000 | -100.0% | -11.60% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 32 | Q3 2023 | 55.2% |
| BEIGENE LTD | 31 | Q3 2023 | 15.6% |
| KURA ONCOLOGY INC. | 24 | Q3 2021 | 4.7% |
| ROCKET PHARMACEUTICALS INC | 23 | Q3 2023 | 5.4% |
| DBV TECHNOLOGIES S A | 23 | Q3 2023 | 3.9% |
| MEI PHARMA INC | 21 | Q2 2023 | 1.4% |
| SYNDAX PHARMACEUTICALS INC | 20 | Q3 2021 | 3.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 4.7% |
| ODONATE THERAPEUTICS INC | 18 | Q1 2022 | 12.5% |
| ESPERION THERAPEUTICS INC NE | 18 | Q2 2021 | 11.0% |
View Boxer Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| IDEAYA Biosciences, Inc. | February 14, 2023 | 2,202,812 | 4.6% |
| Milestone Pharmaceuticals Inc. | February 14, 2023 | 698,861 | 2.0% |
| SpringWorks Therapeutics, Inc. | September 19, 2022 | 3,421,541 | 5.7% |
| iTeos Therapeutics, Inc. | May 11, 2022 | 2,154,058 | 6.1% |
| Atreca, Inc. | February 14, 2022 | 2,202,333 | 7.2% |
| Biomea Fusion, Inc. | February 14, 2022 | 1,188,405 | 4.1% |
| Cabaletta Bio, Inc. | February 14, 2022 | 540,000 | 1.9% |
| CymaBay Therapeutics, Inc. | February 14, 2022 | ? | ? |
| DBV Technologies S.A. | February 14, 2022 | 1,067,299 | 1.9% |
| Elevation Oncology, Inc. | February 14, 2022 | 872,780 | 3.8% |
View Boxer Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-22 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-12 |
| 4 | 2024-02-08 |
| SC 13D/A | 2024-02-08 |
| 4 | 2024-01-25 |
| SC 13D/A | 2024-01-25 |
| SC 13G | 2024-01-18 |
| SC 13D/A | 2023-12-18 |
View Boxer Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.